Renaissance Technologies - SILVERBACK THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Renaissance Technologies ownership history of SILVERBACK THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$521
-74.4%
137,700
-54.7%
0.00%
-66.7%
Q2 2023$2,039
-5.3%
304,300
-8.0%
0.00%0.0%
Q1 2023$2,152
-18.9%
330,600
+6.3%
0.00%
-25.0%
Q4 2022$2,653
-99.8%
311,000
-1.1%
0.00%
+100.0%
Q3 2022$1,660,000
-28.7%
314,400
-42.8%
0.00%
-33.3%
Q2 2022$2,329,000
-1.1%
549,299
-18.1%
0.00%0.0%
Q1 2022$2,354,000
-4.0%
670,542
+82.2%
0.00%0.0%
Q4 2021$2,451,000
+110.6%
368,000
+215.6%
0.00%
+50.0%
Q3 2021$1,164,000116,6000.00%
Other shareholders
SILVERBACK THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
SR ONE CAPITAL MANAGEMENT, LP 4,012,903$15,168,7737.77%
Nextech Invest Ltd. 1,910,029$7,219,9102.19%
K2 PRINCIPAL FUND, L.P. 2,552,062$9,646,7942.02%
Charles Schwab Trust Co 4,246,071$16,050,1481.81%
Sio Capital Management, LLC 1,105,911$4,180,3441.29%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 11,077,927$41,874,5640.92%
SECTORAL ASSET MANAGEMENT INC 1,049,191$3,965,9420.77%
Orbimed Advisors 9,240,887$34,930,5530.74%
RA Capital Management 9,459,678$35,757,5830.70%
K2 PRINCIPAL FUND, L.P. 688,900$2,604,0420.55%
View complete list of SILVERBACK THERAPEUTICS INC shareholders